REGENERON PHARMACEUTICALS INC. - Daily - Technical analysis published on 10/25/2019 (GMT)
- 398
- 0
- Who voted?
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Court terme:
Strongly bullish
De fond:
Bullish
Technical indicators
72%
0%
28%
My opinion
Bullish above 305.29 USD
My targets
320.07 USD (+4.68%)
335.88 USD (+9.85%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on REGENERON PHARMACEUTICALS INC. as long as the price remains well above 305.29 USD. The buyers” bullish objective is set at 320.07 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 335.88 USD. If there is any crossing, the next objective would be the resistance located at 391.80 USD.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
FORCE
0
10
7
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The REGENERON PHARMACEUTICALS INC. rating is 305.77 USD. The price registered an increase of +0.25% on the session with the lowest point at 299.22 USD and the highest point at 306.09 USD. The deviation from the price is +2.19% for the low point and -0.10% for the high point.299.22
306.09
305.77
The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of REGENERON PHARMACEUTICALS INC. in Daily shows an overall bullish trend. The signals returned by the moving averages are 78.57% bullish. This bullish trend is reinforced by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner is currently detecting several bullish signals that could impact this trend:
Bullish trend reversal : Moving Average 100
Type : Bullish
Timeframe : Daily
Bullish trend reversal : adaptative moving average 100
Type : Bullish
Timeframe : Daily
An assessment of technical indicators shows a strong bullish signal.
But beware of excesses. The Central Indicators scanner currently detects this:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Near horizontal resistance
Type : Bearish
Timeframe : Daily
Near resistance of channel
Type : Bearish
Timeframe : Daily
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 187.74 | 284.40 | 305.29 | 305.77 | 320.07 | 335.88 | 391.80 |
| Change (%) | -38.60% | -6.99% | -0.16% | - | +4.68% | +9.85% | +28.14% |
| Change | -118.03 | -21.37 | -0.48 | - | +14.30 | +30.11 | +86.03 |
| Level | Minor | Major | Intermediate | - | Intermediate | Intermediate | Minor |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 293.04 | 296.25 | 300.64 | 303.85 | 308.24 | 311.45 | 315.84 |
| Camarilla | 302.93 | 303.63 | 304.32 | 305.02 | 305.72 | 306.41 | 307.11 |
| Woodie | 293.62 | 296.55 | 301.22 | 304.15 | 308.82 | 311.75 | 316.42 |
| Fibonacci | 296.25 | 299.16 | 300.95 | 303.85 | 306.76 | 308.55 | 311.45 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 283.73 | 291.00 | 295.60 | 302.87 | 307.47 | 314.74 | 319.34 |
| Camarilla | 296.93 | 298.01 | 299.10 | 300.19 | 301.28 | 302.37 | 303.45 |
| Woodie | 282.39 | 290.33 | 294.26 | 302.20 | 306.13 | 314.07 | 318.00 |
| Fibonacci | 291.00 | 295.54 | 298.34 | 302.87 | 307.41 | 310.21 | 314.74 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 237.24 | 254.31 | 265.85 | 282.92 | 294.46 | 311.53 | 323.07 |
| Camarilla | 269.53 | 272.16 | 274.78 | 277.40 | 280.02 | 282.65 | 285.27 |
| Woodie | 234.49 | 252.93 | 263.10 | 281.54 | 291.71 | 310.15 | 320.32 |
| Fibonacci | 254.31 | 265.24 | 271.99 | 282.92 | 293.85 | 300.60 | 311.53 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 63.13 | |
| MACD (12,26,9): | 4.5000 | |
| Directional Movement: | 3.38 | |
| AROON (14): | 42.86 | |
| DEMA (21): | 301.27 | |
| Parabolic SAR (0,02-0,02-0,2): | 287.70 | |
| Elder Ray (13): | 3.77 | |
| Super Trend (3,10): | 282.38 | |
| Zig ZAG (10): | 305.77 | |
| VORTEX (21): | 1.0500 | |
| Stochastique (14,3,5): | 82.18 | |
| TEMA (21): | 305.89 | |
| Williams %R (14): | -14.16 | |
| Chande Momentum Oscillator (20): | 20.67 | |
| Repulse (5,40,3): | 1.3400 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.1600 | |
| Courbe Coppock: | 15.17 |
| MA7: | 301.61 | |
| MA20: | 292.22 | |
| MA50: | 290.02 | |
| MA100: | 297.92 | |
| MAexp7: | 302.03 | |
| MAexp20: | 296.22 | |
| MAexp50: | 294.46 | |
| MAexp100: | 303.72 | |
| Price / MA7: | +1.38% | |
| Price / MA20: | +4.64% | |
| Price / MA50: | +5.43% | |
| Price / MA100: | +2.63% | |
| Price / MAexp7: | +1.24% | |
| Price / MAexp20: | +3.22% | |
| Price / MAexp50: | +3.84% | |
| Price / MAexp100: | +0.67% |
News
The last news published on REGENERON PHARMACEUTICALS INC. at the time of the generation of this analysis was as follows:
- Regeneron Ranked #2 in Science Magazine's Top Biopharma Companies to Work For
- Regeneron Colleagues Support 150 Community Organizations During Third Annual Day for Doing Good
- Regeneron Announces Upcoming Investor Conference Presentations
- Regeneron to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2019
- The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis REGENERON PHARMACEUTICALS INC. - Daily